xamoterol has been researched along with digitoxin in 4 studies
| Studies (xamoterol) | Trials (xamoterol) | Recent Studies (post-2010) (xamoterol) | Studies (digitoxin) | Trials (digitoxin) | Recent Studies (post-2010) (digitoxin) |
|---|---|---|---|---|---|
| 269 | 80 | 17 | 5,259 | 90 | 219 |
| Protein | Taxonomy | xamoterol (IC50) | digitoxin (IC50) |
|---|---|---|---|
| STAT3, partial | Homo sapiens (human) | 0.7 | |
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Sodium/potassium-transporting ATPase subunit alpha-1 | Homo sapiens (human) | 0.008 | |
| Sodium/potassium-transporting ATPase subunit beta-1 | Homo sapiens (human) | 0.008 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.23 | |
| Sodium/potassium-transporting ATPase subunit alpha-3 | Homo sapiens (human) | 0.008 | |
| Sodium/potassium-transporting ATPase subunit beta-2 | Homo sapiens (human) | 0.008 | |
| Sodium/potassium-transporting ATPase subunit alpha-2 | Homo sapiens (human) | 0.008 | |
| Sodium/potassium-transporting ATPase subunit alpha-1 | Canis lupus familiaris (dog) | 0.008 | |
| Sodium/potassium-transporting ATPase subunit beta-3 | Homo sapiens (human) | 0.008 | |
| Sodium/potassium-transporting ATPase subunit gamma | Homo sapiens (human) | 0.008 | |
| Sodium/potassium-transporting ATPase subunit alpha-4 | Homo sapiens (human) | 0.008 | |
| Solute carrier organic anion transporter family member 4C1 | Homo sapiens (human) | 0.12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Fukuda, K; Handa, S; Kawamura, Y; Nakamura, Y; Ogawa, S | 1 |
| Cobelli, F; Febo, O | 1 |
1 review(s) available for xamoterol and digitoxin
| Article | Year |
|---|---|
[Exercise test in the evaluation of the efficacy of drug therapy].
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cardiotonic Agents; Clinical Trials as Topic; Deoxyepinephrine; Digitalis; Evaluation Studies as Topic; Exercise Test; Follow-Up Studies; Heart Failure; Humans; Oxygen Consumption; Plants, Medicinal; Plants, Toxic; Time Factors; Vasodilator Agents; Xamoterol | 2000 |
3 other study(ies) available for xamoterol and digitoxin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[How to select newly-developed oral inotropic agents: an evaluation based on their effects on heart rate and arrhythmias].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Dilated; Cardiotonic Agents; Circadian Rhythm; Digitalis; Drug Evaluation; Electrocardiography, Ambulatory; Ethanolamines; Female; Heart Rate; Humans; Male; Middle Aged; Plants, Medicinal; Plants, Toxic; Propanolamines; Pyrazines; Quinolines; Xamoterol | 1990 |